Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1386594

registered interest
date	09/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Heart Diseases: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to reassure people experiencing symptoms of heart valve disease that they will have access to a face to face GP appointment during the covid-19 booster vaccine rollout.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	90402
answer	answer is ministerial correction date of answer 20/12/2021 answer text <p>General practices will remain open but have been asked to prioritise vaccinations and emergency care for the rest of the year. General practitioners will still be able to refer patients with a heart condition to one of 40 new diagnostic centres to access detection and diagnostic checks closer to home.</p> answering member constituency Lewes answering member printed Maria Caulfield grouped question UIN 92141 question first answered 20/12/2021 10:29:28 answering member 4492 label Biography information for Maria Caulfield
tabling member	3960 label Biography information for Henry Smith

1383942

registered interest
date	01/12/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Diagnosis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what the timescale is for HNS England's evaluation report on the performance of Rapid Diagnostic Centres.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	85238
answer	answer is ministerial correction date of answer 09/12/2021 answer text <p>Ipsos MORI, in collaboration with the Midlands and Lancashire Commissioning Support Unit and York Health Economics Consortium, have been commissioned to undertake a four year evaluation of the rapid diagnostic centre programme until the end of 2023/24. Throughout the evaluation, Ipsos MORI and their partners will produce quarterly and annual reports. The first annual report will be published shortly. The final report is due in March 2024.</p> answering member constituency Charnwood answering member printed Edward Argar question first answered 09/12/2021 13:51:18 answering member 4362 label Biography information for Edward Argar
tabling member	3960 label Biography information for Henry Smith

1382909

registered interest
date	29/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what proportion of immunocompromised or immunosuppressed people have received (a) a Moderna third covid-19 vaccine dose and (b) the correct quantity of Moderna as a third dose.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	83308
answer	answer is ministerial correction date of answer 10/01/2022 answer text <p>The information is not held in the format requested. Whilst data for Moderna vaccine administrations is collected, information by clinical risk groups is not held centrally.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 10/01/2022 12:44:07 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1382910

registered interest
date	29/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Immunosuppression: Coronavirus
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what measures are in place to ensure immunocompromised people’s covid-19 vaccine records are amended where third doses have been incorrectly recorded as boosters.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	83309
answer	answer is ministerial correction date of answer 02/02/2022 answer text <p>For those who are severely immunosuppressed, the third primary COVID-19 vaccine dose is recorded as a booster vaccinations. A subsequent booster or fourth dose for eligible severely immunosuppressed patients after a further three months will be recorded as a second booster. Existing data systems support the recording of multiple boosters. All doses administered appear in an individual’s vaccination history and are recorded in the National Immunisation Management System and general practitioner record. An assessment determined that retrospectively updating or amending patient records in the immediate term could risk creating a data quality issue.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 83310 question first answered 02/02/2022 11:38:33 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1382911

registered interest
date	29/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Coronavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when covid-19 vaccine records will be amended to show third doses that have been incorrectly recorded as boosters.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	83310
answer	answer is ministerial correction date of answer 02/02/2022 answer text <p>For those who are severely immunosuppressed, the third primary COVID-19 vaccine dose is recorded as a booster vaccinations. A subsequent booster or fourth dose for eligible severely immunosuppressed patients after a further three months will be recorded as a second booster. Existing data systems support the recording of multiple boosters. All doses administered appear in an individual’s vaccination history and are recorded in the National Immunisation Management System and general practitioner record. An assessment determined that retrospectively updating or amending patient records in the immediate term could risk creating a data quality issue.</p> answering member constituency Erewash answering member printed Maggie Throup grouped question UIN 83309 question first answered 02/02/2022 11:38:33 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1382912

registered interest
date	29/11/2021
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Casirivimab/imdevimab
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment he has made of the impact of the B.1.1.529 covid-19 variant on the (a) efficacy of Ronapreve and (b) efficacy of Ronapreve in immunocompromised people.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	83311
answer	answer is ministerial correction date of answer 14/12/2021 answer text <p>The UK Health Security Agency have noted that B.1.1.529, or Omicron, could potentially have an impact on neutralising monoclonal antibody treatments. However, there is currently no confirmed evidence of reduced efficacy.</p><p>Regeneron is evaluating Ronapreve against the Omicron variant. Preliminary analyses from the company suggest that the antibodies in the cocktail may have the potential to retain activity against the Omicron variant, as well as the other existing variants of concern. Further in vitro data is expected over the next month.</p><p>On 17 September, Ronapreve was made available to treat the most vulnerable hospital patients in the United Kingdom through an interim clinical policy. This treatment will continue to be available this winter for hospitalised patients.</p><p>There will be ongoing monitoring (involving sample collection) of selected patients treated with nMABs (led by UK Health Security Agency). This will include monitoring the efficacy of the treatments against variants. The Therapeutics and Antivirals Taskforce will also keep the evidence under review, including how this could affect immunocompromised patients.</p> answering member constituency Erewash answering member printed Maggie Throup question first answered 14/12/2021 11:45:26 answering member 4447 label Biography information for Maggie Throup
tabling member	3960 label Biography information for Henry Smith

1381260

registered interest
date	23/11/2021
answering body	Department for Digital, Culture, Media and Sport
answering dept id	10
answering dept short name	Digital, Culture, Media and Sport
answering dept sort name	Digital, Culture, Media and Sport
hansard heading	Gambling: Reform
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Digital, Culture, Media and Sport, whether her Department plans to include consideration in the Gambling Act review of the introduction of testing for new amusement machines and games to gather evidence on regulatory reforms and social responsibility measures.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	80278
answer	answer is ministerial correction date of answer 26/11/2021 answer text <p>As part of its broad scope, our Gambling Act Review call for evidence included questions on the rules governing land based gambling and the need to ensure an equitable approach to the regulation of the online and the land based industries.</p><p>We are carefully considering all the evidence submitted and a white paper setting out our next steps and proposals for reform will be published in due course.</p><p> </p> answering member constituency Croydon South answering member printed Chris Philp grouped question UIN 80279 question first answered 26/11/2021 11:38:11 answering member 4503 label Biography information for Chris Philp
tabling member	3960 label Biography information for Henry Smith

1381261

registered interest
date	23/11/2021
answering body	Department for Digital, Culture, Media and Sport
answering dept id	10
answering dept short name	Digital, Culture, Media and Sport
answering dept sort name	Digital, Culture, Media and Sport
hansard heading	Gambling: Reviews
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Digital, Culture, Media and Sport, if she will make it her policy to undertake regular reviews of the gambling sector to ensure that policy, regulation, stakes and prizes are kept up to date.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	80279
answer	answer is ministerial correction date of answer 26/11/2021 answer text <p>As part of its broad scope, our Gambling Act Review call for evidence included questions on the rules governing land based gambling and the need to ensure an equitable approach to the regulation of the online and the land based industries.</p><p>We are carefully considering all the evidence submitted and a white paper setting out our next steps and proposals for reform will be published in due course.</p><p> </p> answering member constituency Croydon South answering member printed Chris Philp grouped question UIN 80278 question first answered 26/11/2021 11:38:11 answering member 4503 label Biography information for Chris Philp
tabling member	3960 label Biography information for Henry Smith

1379531

registered interest
date	17/11/2021
answering body	Department for Environment, Food and Rural Affairs
answering dept id	13
answering dept short name	Environment, Food and Rural Affairs
answering dept sort name	Environment, Food and Rural Affairs
hansard heading	Trapping
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Environment, Food and Rural Affairs, what assessment he has made of the effectiveness of snare traps; and if he will make a statement.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	76640
answer	answer is ministerial correction date of answer 10/12/2021 answer text <p>While some people consider snares to be an inhumane and unnecessary means of trapping wild animals, others maintain they are an essential tool in controlling foxes and rabbits.</p><p> </p><p>There is a code of practice for the use of snares to control foxes in England which sets out clear principles for the legal and humane use of snares, using evidence from snare-use research to improve their deployment and design. The Wildlife and Countryside Act 1981 also prohibits the use of self-locking snares and the setting of any type of snare in places where they are likely to catch certain non-target animals such as badgers. It also requires snares to be inspected on a daily basis.</p><p> </p><p>However, when used improperly, snares can cause immense suffering to both target and non-target animals including pet cats and dogs. The use of snares is therefore an issue we are looking at closely as part of our continued drive to maintain the highest animal welfare standards in the world.</p><p> </p><p>Through the Government’s Animal Action for Welfare Plan, published in May of this year, we are looking at whether changes need to be made to reflect concerns raised.</p> answering member constituency Taunton Deane answering member printed Rebecca Pow question first answered 10/12/2021 14:52:44 answering member 4522 label Biography information for Rebecca Pow
tabling member	3960 label Biography information for Henry Smith

1377891

registered interest
date	12/11/2021
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Animal Experiments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, with reference to the Animals in Science Committee's report entitled Review of the harm benefit analysis in the use of animals in research, what steps her Department has taken to implement the 17 recommendations pertaining to the regulatory framework around the Animals (Scientific Procedures) Act 1986.
tabling member constituency	Crawley
tabling member printed	Henry Smith
uin	73802
answer	answer is ministerial correction date of answer 23/11/2021 answer text <p>The Home Office responded to the Animals in Science Committee’s (ASC) report on a review of harm-benefit analysis in the use of animals in research on 21 May 2020.</p><p>The Home Office accepted the 17 recommendations pertaining to the Animals (Scientific Procedures) Act 1986 and indicated how it intended to implement the recommendations.</p><p>The Home Office has regularly updated the ASC and stakeholders on progress, and wider issues, at scheduled meetings. In particular, the Home Office has updated ASC and stakeholders on reforms to the regulatory delivery model, including the approach to audit, and updates to the e-licensing system. Further information is available at: <a href="http://www.gov.uk/guidance/research-and-testing-using-animals" target="_blank">www.gov.uk/guidance/research-and-testing-using-animals</a>.</p> answering member constituency East Hampshire answering member printed Damian Hinds question first answered 23/11/2021 13:33:43 answering member 3969 label Biography information for Damian Hinds previous answer version 33867 answering member constituency East Hampshire answering member printed Damian Hinds answering member 3969 label Biography information for Damian Hinds
tabling member	3960 label Biography information for Henry Smith